Home - CIMIT MAIN

Responsive Image
The FDA has approved the first rapid hepatitis C virus test for the U.S. market that can be used in patient care settings. The test, which was validated in part by the NIH RADx Tech program with funding from CDC, can provide results in about one hour, meaning patients with a positive test can begin treatment right away. We're honored to have been a part of the journey behind this important milestone! 

Learn more about this game changer for hepatitis C diagnosis >

Programs and Offerings

Back

Error

News and Events

Funding Opportunity for Neurotech Innovations: Apply for funding up to $500K

Read MoreAboutFunding Opportunity for Neurotech Innovations: Apply for funding up to $500K »

Rapid Acceleration of Diagnostics Technology (RADx® Tech) Advancing Cures and Therapies and ending ENDOmetriosis diagnostic delays (ACT ENDO) Challenge

Read MoreAboutRapid Acceleration of Diagnostics Technology (RADx® Tech) Advancing Cures and Therapies and ending ENDOmetriosis diagnostic delays (ACT ENDO) Challenge »

IEEE HI-POCT 2024: Premier Conference on Health Innovations in Point-of-Care Technology

September 19-20, 2024 at University of Arizona Read MoreAboutIEEE HI-POCT 2024: Premier Conference on Health Innovations in Point-of-Care Technology »

FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test

Test Enables Single-Visit Testing and Treatment for Hepatitis C Read MoreAboutFDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test »

Funding Opportunity: Innovate4Kids Initiative for Medical Devices Addressing Youth Substance Use Disorders and Addiction

Read MoreAboutFunding Opportunity: Innovate4Kids Initiative for Medical Devices Addressing Youth Substance Use Disorders and Addiction »

NIH collaborates with diagnostics manufacturers on obtaining authorization of multiplex tests

Read MoreAboutNIH collaborates with diagnostics manufacturers on obtaining authorization of multiplex tests »

NIH awards interim prizes in fetal diagnostic and monitoring technology competition

Read MoreAboutNIH awards interim prizes in fetal diagnostic and monitoring technology competition »

A new RADx® Tech fellowship helps underrepresented innovators advance their technology

Fellows share their perspectives on the unique program Read MoreAboutA new RADx® Tech fellowship helps underrepresented innovators advance their technology »

NIH Blueprint MedTech spurs innovation in diagnosing and treating nervous system disorders

Read MoreAboutNIH Blueprint MedTech spurs innovation in diagnosing and treating nervous system disorders »

GAITS Platform October 2023 Update

Read MoreAboutGAITS Platform October 2023 Update »

C-THAN Receives up to $8 Million in Funding over Five Years

The Center for Innovation in Point-of-Care Technologies for HIV/AIDS and Emerging Infectious Diseases at Northwestern University (C-THAN), housed within Northwestern Engineering’s Center for Innovation Global Health Technologies (CIGHT), has received up to $8 million in renewal funding over five years from the National Institutes of Health (NIH). Read MoreAboutC-THAN Receives up to $8 Million in Funding over Five Years »

Connect with Us

Our Lasting Impact

As an early pioneer in managing translational research, Cimit has directly supported over 1,200 innovator teams and reviewed or consulted on over 5,000 ideas since our founding in 1998.

We work collaboratively with healthtech innovators, entrepreneurs, and institutions to ultimately make a positive impact on patient care across the globe. We streamline pathways to progress through our efficient processes, established systems, and unparalleled market expertise.